Introduction
From Clinical Trials to RWE in PsO, PsA and RA
Objectives
•Present current scientific evidence, including clinical trials, Real-world data, and illustrative case studies, on the management of PsO, PsA and RA.
•Communicate Ixekizumab and Baricitinib value proposition to highlight what the product may mean to people living with Plaque Psoriasis (PsO), Psoriatic Arthritis (PsA) & Rheumatoid Arthritis (RA) respectively.
This Course For :
Physician
( Dermatology , Rheumatology )
Resident / Fellow
( Dermatology , Rheumatology )
Pharmacy
Speaker
Dr.Faris Alkhayyal
Advance clinical Dermatology Consultant
Prince Sultan Military Medical City
Dr Mohamed Al Mansour
Head of Rheumatology, Section in King Fahad Medical City,
Riyadh, KSA.
Assistant Professor at Al Faisal University, Riyadh, KSA
Dr Abdelrahman Hozaimy
Consultant at Alhabib Medical Group and Reveal Clinic in Riyadh.
Provided by :
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
15 Oct 2025 To 15 Oct 2025 -
09:30 PM To 10:45 PM 
Certificate Available 
Online Click Here
- 141
Add to Calendar
10/15/2025 09:30 PM
10/15/2025 10:45 PM
Asia/ Riyadh
Transition from Clinical Trials to RWE in Plaque Psoriasis, Psoriatic Arthritis & Rheumatoid Arthritis
Transition from Clinical Trials to RWE in Plaque Psoriasis, Psoriatic Arthritis & Rheumatoid Arthritis
https://medicalacademy.org/portal/event/view/2463
